Table 1

 Summary of prevalence studies of autism spectrum disorders (42 studies)

Ref.Publ. yearFirst authorCountrySample sizeAreaAge (years)Sample screened§Screen methods¶Prospective(P)/retrospective (R) assessmentTypical autismAll ASD
Diagnostic criteria usedPrevalence estimate (per 10 000) (SE)Diagnostic criteria usedPrevalence estimate (per 10 000) (SE)
*Estimated from number of cases and prevalence estimate; †Cohort first screened at 18 months, followed up until age 7–8 years; ‡Data from an older cohort also included in the study, but excluded from these analyses; §Sample screened: P, whole population; C, general clinical services; S, specialist clinical/educational services; ¶Screen methods: C, routine checks; L, letter to elicit referrals; Q, questionnaires/interview; R, records (CHAT, Checklist for Autism in Toddlers; DAWBA, Development and Well-Being Assessment); **ICD-10 used for analysis; ††DSM-IV used for analysis.
141966LotterUK78 000Urban8–10PQPKanner4.5 (0.76)
151970TreffertUSA899 750Mixed0–12CRRKanner0.7 (0.09)
161970BraskDenmark46 500Urban2–14SKanner4.3 (0.96)
171979WingUK35 000Urban0–15CRPKanner4.9 (1.18)Triad21.2 (2.46)
181982HoshinoJapan609 848Mixed0–18PLPKanner2.33 (0.20)
191983IshiiJapan34 987Urban6–12PLPRutter16.0 (2.14)
201983BohmanSweden69 000Mixed0–20PLPRutter3.0 (0.66)Rutter5.6 (0.9)
211984McCarthyIreland65 000Mixed8–10SRRKanner4.3 (0.81)
221984GillbergSweden128 584Mixed4–18PLPRutter2.0 (0.39)Rutter3.9 (0.55)
231986SteinhausenGermany279 616Urban0–15SLRRutter1.9 (0.26)
241986SteffenburgSweden42 886Mixed0–9PLPDSM-III4.7 (1.05)DSM-III6.9 (1.27)
251987BurdUSA180 986Mixed2–18CLPDSM-III1.2 (0.26)DSM-III3.3 (0.43)
261987MatsuishiJapan32 834Urban4–12PRPDSM-III15.5 (2.17)
271988TanoueJapan95 394Rural7PCPDSM-III13.8 (1.20)
281988BrysonCanada20 800Mixed6–14PQPDSM-III1.9 (0.96)Denkla Triad10.1 (2.2)
291989RitvoUSA526 514Mixed3–17PLPDSM-III2.92 (0.24)
301989SugiyamaJapan11 320Urban1.5PCPDSM-III13.0 (3.37)
311989CialdellaFrance135 180Urban5–9CLRDSM-III5.1 (0.61)DSM-III10.8 (0.89)
321991GillbergSweden78 102Mixed4–13CLPDSM-III-R7.0 (0.95)DSM-III-R9.4 (1.1)
331992OhtakiJapan35 366Mixed6–14SRPDSM-III-R13.9 (1.98)
341992FombonneFrance274 816Mixed9 & 13CRRICD-94.9 (0.42)
351993HerderNorway50 909*1–17CDSM-III-R5.5 (1.04)
361996HondaJapan8 537Urban5PCPICD-1021.1 (4.97)
371997ArvidssonSweden1 941Mixed3–6PCPICD-1031 (12.6)ICD-1046 (15.36)
381997WebbUK73 300Mixed3–15PLPDSM-III-R7.2 (0.98)
391997FombonneFrance325 347Mixed6–16CRRICD-105.35 (0.41)ICD-1016.29 (0.71)
401998SponheimNorway65 688Mixed3–14PLPICD-103.8 (0.76)ICD-105.2 (0.89)
411999KadesjoSweden826Urban6–7PLPICD-1060 (26.87)Gillberg’s criteria121 (38.04)
422000PowellUK16 049*Mixed0 to <5SRRDSM-III-R or ICD-10**16.2 (3.17)ICD-1033.7 (1.48)
432000KielinenFinland152 732Mixed3–18CRRICD-105.6 (0.61)ICD-1013.9 (0.95)
442000BairdUK16 235Urban1.5†PQ (CHAT)PICD-1030.8 (4.35)ICD-1057.9 (5.95)
452001MagnussonIceland43 153Mixed5–14‡PCRICD-108.6 (1.41)ICD-1013.2 (1.75)
462001BertrandUSA8 896Urban3–10PRP (where possible)DSM-IV40.0 (6.69)DSM-IV67 (8.65)
472001ChakrabartiUK15 500Mixed2.5–6.5PCPDSM-IV16.8 (3.29)DSM-IV62.6 (6.34)
482002CroenUSA4 590 333Mixed0–12SRRDSM-III & DSM-IV††11.0 (0.15)
492003LingamUK186 206Mixed5–14SRRICD-1014.9 (0.89)ICD-1030.4 (1.28)
502004TebrueggeUK2 536Mixed8–9PRRICD-1023.7 (9.7)ICD-1082.8 (18.0)
ASD papers
512001FombonneUK10 438Mixed5–15PQ (DAWBA)PDSM-IV and ICD-10 (excl Rett’s)26.1 (5.0)
522002ScottUK43 472Mixed5–11PLRICD-1057.0 (3.61)
532003Yeargin-AllsoppUSA289 456Urban3–10CRRDSM-IV34 (1.08)